Analysts chose Bharat Forge Ltd., BSE Ltd., Glenmark Pharmaceuticals Ltd., Metropolis Healthcare Ltd., and Tata Chemicals Ltd. for Wednesday’s trading session.

The Street Founder Kunal Rambhia and Angel One Technical and Derivative Research Chief Manager Osho Krishnan shared their views on the above-mentioned stocks.

Bharat Forge 

Rambhia recommended a buy for the stock with a target price of Rs 1,300 apiece. The current target price implied a 2.5% upside from Tuesday’s close price. The stop loss is at Rs 1,255 apiece.

Out of 29 analysts tracking the company, 13 maintain a ‘buy’ rating, seven recommend a ‘hold’, and nine suggest ‘sell’, according to Bloomberg data. The average 12-month consensus price target implies a downside of 9.4%.

BSE 

Rambhia recommended a ‘Buy’ for the stock. The target price is Rs 2,850 apiece, which implied a 3.3% upside from Tuesday’s close price. The stop loss is at Rs 2,750.

Out of 14 analysts tracking the company, 10 maintain a ‘buy’ rating, three recommend a ‘hold’, and one suggests ‘sell’, according to Bloomberg data. The average 12-month consensus price target implies a downside of 14.7%.

Glenmark Pharmaceuticals 

Krishnan suggested a buy for the stock. The target price for the stock is Rs 1,570, which implies a 3.8% upside from Tuesday’s close price. The stop loss for the stock is Rs 1,470.

Out of 12 analysts tracking the company, eight maintain a ‘buy’ rating, three recommend a ‘hold’, and one suggests ‘sell’, according to Bloomberg data. The average 12-month consensus price target implies an upside of 10.6%.

Metropolis Healthcare 

Metropolis Healthcare Ltd. got a buy recommendation from Rambhia. The target price for the stock is Rs 1,800 apiece, which implies a 5.3% upside from Tuesday’s close price. The stop loss is at Rs 1,690 apiece.

Out of 24 analysts tracking the company, 18 maintain a ‘buy’ rating, two recommend a ‘hold’, and four suggest ‘sell’, according to Bloomberg data. The average 12-month consensus price target implies an upside of 12.5%.

Tata Chemicals 

Krishnan suggested a buy for Tata Chemicals Ltd. with a target price of Rs 940, which implied a 3.5% upside from Tuesday’s close price. The stop loss is at Rs 875 apiece.

Out of eight analysts tracking the company, one recommends a ‘hold’, and seven suggest ‘sell’, according to Bloomberg data. The average 12-month consensus price target implies a downside of 17.3%.

. Read more on Markets by NDTV Profit.For Wednesday’s session analysts chose from various sectors including healthcare, defence, and pharmaceuticals.  Read MoreMarkets, Notifications 

​NDTV Profit